Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Peruzzi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|August 4, 2009
Engineered adenovirus serotypes for overcoming anti-vector immunitySridhar Dharmapuri, Daniela Peruzzi, Luigi Aurisicchio
Vaccine|December 1, 2009
Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogsDaniela Peruzzi, Giuseppe Mesiti, Gennaro Ciliberto, et al.
Human Gene Therapy|November 8, 2013
Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical modelsLuigi Aurisicchio, Daniela Peruzzi, Gloria Koo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responsesAntonella Conforti, Daniela Peruzzi, Patrizia Giannetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
MMP11: a novel target antigen for cancer immunotherapyDaniela Peruzzi, Federica Mori, Antonella Conforti, et al.
Biochimica Et Biophysica Acta|September 6, 2002
Molecular characterization of the human PLC beta1 geneDaniela Peruzzi, Michela Aluigi, Lucia Manzoli, et al.
Human Gene Therapy|October 22, 2008
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomasFederica Mori, Patrizia Giannetti, Daniela Peruzzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2010
A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphomaDaniela Peruzzi, Alessandra Gavazza, Giuseppe Mesiti, et al.
Human Gene Therapy|August 2, 2013
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphomaAlessandra Gavazza, George Lubas, Arthur Fridman, et al.
Oncoimmunology|December 18, 2012
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platformArthur Fridman, Adam C Finnefrock, Daniela Peruzzi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|August 4, 2009
Engineered adenovirus serotypes for overcoming anti-vector immunitySridhar Dharmapuri, Daniela Peruzzi, Luigi Aurisicchio
Vaccine|December 1, 2009
Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogsDaniela Peruzzi, Giuseppe Mesiti, Gennaro Ciliberto, et al.
Human Gene Therapy|November 8, 2013
Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical modelsLuigi Aurisicchio, Daniela Peruzzi, Gloria Koo, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 30, 2009
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responsesAntonella Conforti, Daniela Peruzzi, Patrizia Giannetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
MMP11: a novel target antigen for cancer immunotherapyDaniela Peruzzi, Federica Mori, Antonella Conforti, et al.
Biochimica Et Biophysica Acta|September 6, 2002
Molecular characterization of the human PLC beta1 geneDaniela Peruzzi, Michela Aluigi, Lucia Manzoli, et al.
Human Gene Therapy|October 22, 2008
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomasFederica Mori, Patrizia Giannetti, Daniela Peruzzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2010
A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphomaDaniela Peruzzi, Alessandra Gavazza, Giuseppe Mesiti, et al.
Human Gene Therapy|August 2, 2013
Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphomaAlessandra Gavazza, George Lubas, Arthur Fridman, et al.
Oncoimmunology|December 18, 2012
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platformArthur Fridman, Adam C Finnefrock, Daniela Peruzzi, et al.
Pageof 2